Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma

PURPOSE: To evaluate safety and efficacy of combined transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEB) and sorafenib in patients with advanced hepatocellular carcinoma (HCC). PATIENTS AND METHODS: A prospective single-center phase II study was undertaken involving patients...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Oncol
Autori principali: Pawlik, Timothy M., Reyes, Diane K., Cosgrove, David, Kamel, Ihab R., Bhagat, Nikhil, Geschwind, Jean-Francois H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2011
Soggetti:
ORIGINAL REPORTS
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829081/
https://ncbi.nlm.nih.gov/pubmed/21911714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.37.1021
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi